跳至主要内容
临床试验/TCTR20210203004
TCTR20210203004Enrolling By Invitation4 期

The efficacy and safety of diacerein versus placebo in the treatment of chronic low back pain. Double-blind, randomized, placebo controlled trial

Department of Orthopedics, Chiangmai University0 个研究点目标入组 70 人开始时间: 2021年2月3日最近更新:
适应症

试验速览

阶段
4 期
状态
Enrolling By Invitation
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Years 至 80 Years(—)
性别
All

入选标准

  • the outpatients who had low back pain more than 12 weeks

排除标准

  • Hypersensitivity to diacerein, to similar compounds, NSAIDs or to acetaminophen.
  • Serious concomitant medical illness
  • Prior spinal surgery
  • Epidural steroid injection or facet block within 2 months
  • Glucosamine or chondroitin sulfate within 4 months
  • Antidepressant or tranquilizer drugs treatment
  • Inflammatory joint disease (AS, spondyloarthropathy)
  • GI disease (diarrhea symptoms)
  • Laxative drug therapy
  • Hepatic disease (AST or ALT >=2.5 times)
  • History of malignancy
  • Coronary heart disease
  • Chronic kidney disease
  • Upper gastrointestinal hemorrhage

研究者

发起方
Department of Orthopedics, Chiangmai University

相似试验

The efficacy and safety of diacerein versus placebo... | 临床试验